Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Cancer & Clinical Oncology|September 1, 1986
Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trialH Ludwig, A Cortelezzi, W Scheithauer, et al.
Haematology and Blood Transfusion|January 1, 1990
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative GroupU Jehn, R Zittoun, S Suciu, et al.
Leukemia|November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)T de Witte, S Suciu, M Peetermans, et al.
Anti-Cancer Drugs|February 1, 1995
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149L Dirix, G Catimel, I Koier, et al.
Anti-Cancer Drugs|October 3, 1999
KW-2149-induced pulmonary toxicity is not prevented by corticosteroids: a phase I and pharmacokinetic studyD Schrijvers, G Catimel, M Highley, et al.
Case Reports in Oncology|January 24, 2013
Long-term disease control of a non-operable neuroendocrine tumor of the lung with lanreotide: a case studyF Van Fraeyenhove, E De Droogh, N Meireson, et al.
International Journal of Epidemiology|August 1, 1994
Demographic factors associated with HTLV-1 infection in a Gabonese communityJ Y Le Hesran, E Delaporte, C Gaudebout, et al.
Cancer|August 1, 1986
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTCM Hayat, U Jehn, R Willemze, et al.
Acta Clinica Belgica|August 14, 1998
Late relapse of a non-seminomatous germ cell tumour from residual mature teratomaJ Van den Brande, D Schrijvers, P Vroman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies GroupP Schöffski, G Catimel, A S Planting, et al.
Pageof 13